M. Navazesh et al., RELATIONSHIP OF MEDICAL STATUS, MEDICATIONS, AND SALIVARY FLOW-RATES IN ADULTS OF DIFFERENT AGES, Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 81(2), 1996, pp. 172-176
Citations number
45
Categorie Soggetti
Pathology,Surgery,"Dentistry,Oral Surgery & Medicine
Multiple systemic disorders and medications have been reported to caus
e xerostomia or salivary gland hypofunction. The purpose of this study
was to evaluate the relationship among systemic disorders, medication
s, and salivary flow rates. Sixty-three ambulatory dental patients age
d 23 to 82 years were randomly selected. The nature, duration, and num
ber of systemic disorders and medications were documented. Repeated me
asurements of unstimulated whole, chewing-stimulated whole, acid-stimu
lated parotid, and candy-stimulated parotid salivary flow rates were o
btained. Data were analyzed with the Wilcoxon rank-sum test, nonparame
tric multivariate analysis of variance, and Fisher's exact test. For p
ersons with systemic disorders who were taking medication, all salivar
y flow rates were significantly (p = 0.03 - 0.001) lower than the flow
rates in healthy persons. Among persons with at least one systemic di
sorder who were taking medication, those who had been taking medicatio
n for longer than 2 years had significantly lower unstimulated whole s
aliva (p = 0.002), chewing-stimulated whole saliva (p = 0.0004), and c
andy-stimulated parotid saliva (p = 0.02) flow rates than those who ha
d been taking medication for 1 to 2 years. The number of systemic diso
rders significantly (p = 0.02) and negatively affected the acid-stimul
ated parotid salivary rates. The prevalence of salivary hypofunction d
etermined on the basis of unstimulated whole saliva and acid-stimulate
d parotid saliva was significantly higher (p = <0.001, p = 0.007) in t
he those persons with systemic disorders and taking medications. The r
esults suggest that salivary secretion is affected by the number of sy
stemic disorders and duration of the potentially xerogenic medications
.